文献速递心血管外周血管CT

经导管主动脉瓣置换术前计算机断层扫描衍生的冠状动脉斑块特征及狭窄严重程度的预后意义

Prognostic implications of pre-transcatheter aortic valve replacement computed tomography-derived coronary plaque characteristics and stenosis severity.
PubMed 文献 · Eur Radiol · 2024-02-03

本研究纳入427例TAVR术前CTA患者共1072支血管,评估CT-FFR与高危斑块特征(HRPC)对血管导向复合终点(VOCO)的预测价值。低CT-FFR(≤0.80)或≥3个HRPC均与VOCO风险升高相关。在CT-FFR>0.80的血管中,≥3个HRPC仍显著增加VOCO风险,而CT-FFR≤0.80的血管中未见此相对增加。

要点

  • TAVR术前CTA可一站式评估冠状动脉生理狭窄严重程度(CT-FFR)和高危斑块特征。
  • 低CT-FFR(≤0.80)或≥3个HRPC均与血管导向复合终点风险升高独立相关。
  • CT-FFR>0.80时,≥3个HRPC仍显著增加VOCO风险;CT-FFR≤0.80时未见此相对增加。

核心结论

  • 在TAVR候选者中,CT-FFR≤0.80与≥3个HRPC均与不良临床事件风险升高相关,但HRPC的预测价值随CT-FFR类别而异,在CT-FFR阴性(>0.80)血管中增量预测价值更明显,而在CT-FFR阳性(≤0.80)血管中未观察到。

研究设计与样本

  • 研究类型为TAVR术前接受CTA患者的预后研究,纳入427例患者(68.4%为男性)共1072支血管,平均年龄70.6±10.6岁,评估HRPC存在及数量与CT-FFR,参考标准为血管导向复合终点(VOCO)。

诊断标准与关键数值

  • HRPC定义为最小管腔面积<4 mm²、斑块负荷≥70%、低衰减斑块、正性重构、餐巾环征或点状钙化;CT-FFR≤0.80为低CT-FFR组。低CT-FFR组VOCO发生率41.7% vs 15.8%,调整后HR 1.96(95%CI 1.28-2.96,p=0.001);≥3个HRPC组VOCO发生率38.7% vs 16.0%,调整后HR 1.81(95%CI 1.20-2.71,p=0.005);CT-FFR>0.80组中≥3个HRPC vs <3个HRPC的VOCO发生率34.7% vs 13.0%,调整后HR 2.04(95%CI 1.18-3.52,p=0.011)。

临床应用与阅片要点

  • 作者指出,TAVR术前CT可作为临床实践中冠状动脉评估的一站式工具。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The study aimed to investigate the prognostic value of pre-transcatheter aortic valve replacement (TAVR) computed tomography angiography (CTA) in assessing physiological stenosis severity (CTA-derived fractional flow reserve (CT-FFR)) and high-risk plaque characteristics (HRPC).

MATERIALS AND METHODS: Among TAVR patients who underwent pre-procedure CTA, the presence and number of HRPCs (minimum lumen area of < 4 mm2, plaque burden ≥ 70%, low-attenuating plaques, positive remodeling, napkin-ring sign, or spotty calcification) as well as CT-FFR were assessed. The risk of vessel-oriented composite outcome (VOCO, a composite of vessel-related ischemia-driven revascularization, vessel-related myocardial infarction, or cardiac death) was compared according to the number of HRPC and CT-FFR categories.

RESULTS: Four hundred and twenty-seven patients (68.4% were male) with 1072 vessels were included. Their mean age was 70.6 ± 10.6 years. Vessels with low CT-FFR (≤ 0.80) (41.7% vs. 15.8%, adjusted hazard ratio (HRadj) 1.96; 95% confidence interval (CI): 1.28-2.96; p = 0.001) or lesions with ≥ 3 HRPC (38.7% vs. 16.0%, HRadj 1.81; 95%CI 1.20-2.71; p = 0.005) demonstrated higher VOCO risk. In the CT-FFR (> 0.80) group, lesions with ≥ 3 HRPC showed a significantly higher risk of VOCO than those with < 3 HRPC (34.7% vs. 13.0%; HRadj 2.04; 95%CI 1.18-3.52; p = 0.011). However, this relative increase in risk was not observed in vessels with positive CT-FFR (≤ 0.80).

CONCLUSIONS: In TAVR candidates, both CT-FFR and the presence of ≥ 3 HRPC were associated with an increased risk of adverse clinical events. However, the value of HRPC differed with the CT-FFR category, with more incremental predictability among vessels with negative CT-FFR but not among vessels with positive CT-FFR.

CLINICAL RELEVANCE STATEMENT: In transcatheter aortic valve replacement (TAVR) candidates, pre-TAVR CTA provided the opportunity to assess coronary physiological stenosis severity and high-risk plaque characteristics, both of which are associated with worse clinical outcomes.

KEY POINTS: • The current study investigated the prognostic value of coronary physiology significance and plaque characteristics in transcatheter aortic valve replacement patients. • The combination of coronary plaque vulnerability and physiological significance showed improved accuracy in predicting clinical outcomes in transcatheter aortic valve replacement patients. • Pre-transcatheter aortic valve replacement CT can be a one-stop-shop tool for coronary assessments in clinical practice.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Dai N, Tang X, Ling R, et al. Prognostic implications of pre-transcatheter aortic valve replacement computed tomography-derived coronary plaque characteristics and stenosis severity. Eur Radiol. 2024. PMID: 38308681. doi:10.1007/s00330-024-10633-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。